Literature DB >> 12754082

Enhanced angiotensin-mediated responses in the nucleus tractus solitarii of spontaneously hypertensive rats.

Nobuhide Katsunuma1, Kazuyoshi Tsukamoto, Satoru Ito, Katsuo Kanmatsuse.   

Abstract

Studies using an AT(1) receptor antagonist, losartan, demonstrated that depressor and bradycardic responses to angiotensin II (Ang II) injection into the nucleus tractus solitarii (NTS) are mediated via those receptors. We further characterized Ang II-evoked cardiovascular responses in this nucleus in spontaneously hypertensive rats (SHR) using a new, selective AT(1) receptor antagonist, valsartan. In alpha-chloralose-anesthetized Sprague-Dawley (S-D) rats, Wistar-Kyoto (WKY) rats, and SHR, unilateral injection of Ang II into the NTS decreased arterial pressure (AP) and heart rate (HR). This response was eliminated by preinjection of valsartan. Depressor responses were much greater in SHR than in WKY rats. In normotensive rats, bilateral valsartan injection did not alter baseline AP or HR, or baroreceptor reflex index (BRI) calculated as the maximal change in HR (bpm) divided by phenylephrine- or nitroprusside-induced maximal change in mean AP (mmHg). In SHR, this treatment did not alter baseline HR and BRI, but significantly increased AP. Preinjection of valsartan did not alter injected glutamate effects in any strain. Thus, stimulation of AT(1) receptors within the NTS contributes to cardiovascular regulation independently of the baroreceptor reflex and the glutamatergic system. This angiotensinergic system in SHR acts tonically to reduce AP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754082     DOI: 10.1016/s0361-9230(03)00013-3

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  GABAB receptor gene transfer into the nucleus tractus solitarii induces chronic blood pressure elevation in normotensive rats.

Authors:  Bo Li; Qing Liu; Chengluan Xuan; Lirong Guo; Ruofan Shi; Qi Zhang; Stephen T O'Rourke; Kexiang Liu; Chengwen Sun
Journal:  Circ J       Date:  2013-06-25       Impact factor: 2.993

2.  AT₁ angiotensin II receptor and novel non-AT₁, non-AT₂ angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat.

Authors:  Erick A Bourassa; Xiefan Fang; Xia Li; Alan F Sved; Robert C Speth
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

3.  Anteroposterior distribution of AT(1) angiotensin receptors in caudal brainstem cardiovascular regulatory centers of the rat.

Authors:  Erick A Bourassa; Alan F Sved; Robert C Speth
Journal:  Brain Res       Date:  2009-10-14       Impact factor: 3.252

4.  Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Detlev Ganten; Carlos M Ferrario; Debra I Diz
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

5.  Angiotensin II increases GABAB receptor expression in nucleus tractus solitarii of rats.

Authors:  Fanrong Yao; Colin Sumners; Stephen T O'Rourke; Chengwen Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

6.  Angiotensin II enhances GABA(B) receptor-mediated responses and expression in nucleus tractus solitarii of rats.

Authors:  Qi Zhang; Fanrong Yao; Stephen T O'Rourke; Steven Y Qian; Chengwen Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

7.  Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat.

Authors:  Zhiying Shan; Jasenka Zubcevic; Peng Shi; Joo Y Jun; Ying Dong; Tatiane M Murça; Gwyneth J Lamont; Adolfo Cuadra; Wei Yuan; Yanfei Qi; Qiuhong Li; Julian F R Paton; Michael J Katovich; Colin Sumners; Mohan K Raizada
Journal:  Hypertension       Date:  2013-04-01       Impact factor: 10.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.